Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid disorders and plaque imaging.

H S Hecht1

  • 1Heart and Vascular Institute, Morristown, New Jersey 07960, USA. hhecht@aol.com

The American Journal of Cardiology
|July 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes.

Circulation·2001
Same author

Impact of plaque imaging by electron beam tomography on the treatment of dyslipidemias.

The American journal of cardiology·2001
Same author

New developments in atherosclerosis imaging: electron beam tomography.

Current atherosclerosis reports·2001
Same author

Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification.

The American journal of cardiology·2001
Same author

Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women.

Journal of the American College of Cardiology·2001
Same author

Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment.

The American journal of cardiology·2001
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Electron-beam tomography (EBT) plaque imaging can transform prevention by treating asymptomatic patients with calcified plaque as high-risk. Focus should shift to plaque changes, not just lipids, guiding treatment decisions.

Area of Science:

  • Cardiovascular imaging
  • Atherosclerosis research
  • Preventive cardiology

Background:

  • Electron-beam tomography (EBT) offers advanced plaque imaging.
  • Current prevention strategies may not fully address subclinical atherosclerosis.
  • Calcified plaque signifies significant coronary artery disease risk.

Purpose of the Study:

  • To propose a paradigm shift in cardiovascular disease prevention using EBT plaque imaging.
  • To integrate nontraditional parameters into plaque evaluation.
  • To guide therapeutic interventions based on plaque characteristics.

Main Methods:

  • Utilizing electron-beam tomography (EBT) for detailed plaque assessment.
  • Incorporating measurement of nontraditional plaque parameters.

Related Experiment Videos

  • Evaluating asymptomatic patients with significant calcified plaque.

    • Main Results:

    • Significant calcified plaque is identified as a clinical coronary artery disease risk equivalent.
    • Nontraditional plaque parameters provide crucial insights.
    • Subclinical atherosclerosis in asymptomatic individuals is a key treatment target.

    Conclusions:

    • EBT plaque imaging principles can revolutionize preventive cardiology.
    • Treatment decisions should prioritize changes in plaque burden over lipid levels.
    • Early intervention in asymptomatic patients with subclinical atherosclerosis is recommended.